Pacira Pharmaceuticals, Inc. Press Releases

Pacira Pharmaceuticals, Inc. to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
05/08/2013 6:40AM - Business Wire

Pacira Pharmaceuticals, Inc. Reports $10.4 Million in First Quarter EXPAREL Revenue and Full First Quarter 2013 Financial Results
05/08/2013 6:30AM - Business Wire

Two New Studies Support Use of EXPAREL via Infiltration Into the Transversus Abdominis Plane for Postsurgical Pain Control
05/06/2013 4:00PM - Business Wire

Pacira Pharmaceuticals, Inc. Announces Timing for First Quarter 2013 Financial Results Webcast and Conference Call
05/01/2013 6:30AM - Business Wire

New Published Analysis Finds Opioid-Related Adverse Events Increase Hospital Stays, Costs of Care and Risks of Readmission and Mortality
04/25/2013 6:30AM - Business Wire

New Data Support the Benefits of EXPAREL for Postsurgical Analgesia Following Aesthetic Plastic Surgery Procedures
04/12/2013 6:30AM - Business Wire

Pacira Pharmaceuticals, Inc. [PCRX] to Ring The NASDAQ Stock Market Closing Bell
04/05/2013 10:00AM - GlobeNewswire

Pacira Pharmaceuticals, Inc. to Close The NASDAQ Stock Market on April 8, 2013
04/05/2013 6:30AM - Business Wire

Analysis of Postsurgical Pain Management Finds Opioid-Related Adverse Events Drive Longer Hospital Stays, Greater Cost and Higher Likelihood of Readmission
03/27/2013 6:30AM - Business Wire

Pacira Pharmaceuticals, Inc. Reports 2012 Financial Results
03/07/2013 6:30AM - Business Wire

Pacira Pharmaceuticals, Inc. to Present at the Barclays Global Healthcare Conference
03/06/2013 6:30AM - Business Wire

Pacira Pharmaceuticals, Inc. Announces Timing for 2012 Financial Results Webcast and Conference Call
02/28/2013 6:30AM - Business Wire

Pacira Pharmaceuticals, Inc. to Present at the Cowen and Company 33rd Annual Health Care Conference
02/25/2013 6:30AM - Business Wire